Gilead Sciences (GILD) R&D In Process (2019 - 2025)
Historic R&D In Process for Gilead Sciences (GILD) over the last 7 years, with Q3 2025 value amounting to $170.0 million.
- Gilead Sciences' R&D In Process fell 6633.66% to $170.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $473.0 million, marking a year-over-year decrease of 9057.96%. This contributed to the annual value of $4.7 billion for FY2024, which is 30372.29% up from last year.
- Latest data reveals that Gilead Sciences reported R&D In Process of $170.0 million as of Q3 2025, which was down 6633.66% from $61.0 million recorded in Q2 2025.
- In the past 5 years, Gilead Sciences' R&D In Process ranged from a high of $4.1 billion in Q1 2024 and a low of -$11.0 million during Q4 2024
- Moreover, its 5-year median value for R&D In Process was $170.0 million (2025), whereas its average is $430.5 million.
- In the last 5 years, Gilead Sciences' R&D In Process soared by 591250.0% in 2023 and then plummeted by 10317.0% in 2024.
- Quarter analysis of 5 years shows Gilead Sciences' R&D In Process stood at $669.0 million in 2021, then crashed by 76.38% to $158.0 million in 2022, then surged by 119.62% to $347.0 million in 2023, then crashed by 103.17% to -$11.0 million in 2024, then skyrocketed by 1645.45% to $170.0 million in 2025.
- Its R&D In Process was $170.0 million in Q3 2025, compared to $61.0 million in Q2 2025 and $253.0 million in Q1 2025.